Form 4: Ocular Therapeutix Executive Sells Shares
Insider Transaction (Form 4)
Peter Kaiser, Chief Development Officer of Ocular Therapeutix, Inc, sold 3,035 shares of common stock on August 24, 2026 for $10.77 per share.
Summary
- Open-market sale: disposed of 3,035 Common Stock at $10.77 ($32,687) on August 24, 2026; holds 264,378 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $32,687 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Peter Kaiser — Officer (Chief Development Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-24 | Open-market sale | Common Stock | 3,035 | $11 | $32.7K | 264,378 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-24 | Open-market sale (3,035 shares) |
Keywords
insider transaction, Form 4, OCUL, OCULAR THERAPEUTIX, INC, bearish, Peter Kaiser
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.